| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| May 6, 2026 | Sell(S) | 310 | $43.95 | $14K | 119K |
| May 5, 2026 | Sell(S) | 2K | $46.65 | $102K | 119K |
| May 4, 2026 | Option exercise(M) | 4K | — | $0 | 121K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| May 4, 2026 | Grant(A) | 9K | — | $0 | 9K |
| May 4, 2026 | Option exercise(M) | 4K | — | $0 | 4K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001943192-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Travere Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.